The CDSCO has alerted healthcare professionals and consumers about stolen Novo Nordisk products, including semaglutide and insulin injectab...

Novo Nordisk launched it's combination diabetic drug Ryzodeg, priced at Rs 1,595 for 300 units, for people with type II diabetes in India.

Insulin player Novo Nordisk said it is launching long-lasting insulin injection Tresiba in the country soon.

Novo is betting big on Tresiba in the emerging markets after it failed to get an approval for the drug from the US Food and Drug Administra...